Anti-cancer activity of nitrones and observations on mechanism of action

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 4, 2011, Pages 373-379

  Floyd, Robert A ^a   Chandru, Hema K ^a   He, Ting ^a   Towner, Rheal ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Cancer; Colon cancer; Glioblastoma; Liver cancer; Nitrones; NXY 059; PBN

Indexed keywords

2,4 DISULFOPHENYL TERT BUTYLNITRONE; AMINOGUANIDINE; ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 2; FREE RADICAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N TERT BUTYL ALPHA PHENYLNITRONE; NITRIC OXIDE; OKN 007; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER PREVENTION; CANCER SIZE; CANCER SURVIVAL; CARCINOGENESIS; COLON CANCER; DRUG EFFECT; ENZYME INHIBITION; GLIOMA; LIVER CANCER; LOW DRUG DOSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; SPIN TRAPPING; TISSUE PERFUSION; TREATMENT DURATION; TREATMENT RESPONSE; VITAMIN DEFICIENCY; WESTERN BLOTTING;

EID: 79958116230     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011795677517     Document Type: Article

References (50)

1. Floyd R.A., Kopke R.D., Choi C.H., Foster S.B., Doblas S., Towner R.A. Nitrones as therapeutics. Free Radic Biol Med, 2008, 45, 1361-74.
2. Dehouck M.-P., Cecchelli R., Green A.R., Renftel M., Lundquist S. In vitro blood-brain barrier permeability and cerebral endothelial cell uptake of the neuroprotective nitrone compound NXY-059 in normoxic, hypoxic and ischemic conditions. Brain Res, 2002, 995, 229-35.
3. Green A.R., Lanbeck-Vallen K., Ashwood T., Lundquist S., Lindstrom B.E., Jonasson H. et al. Brain penetration of the novel free radical trapping neuroprotectant NXY-059 in rats subjected to permanent focal ischemia. Brain Res, 2006, 1072, 224-6.
4. Chen G., Bray T.M., Janzen E.G., McCay P.B. Excretion, meta-bolism and tissue distribution of a spin trapping agent, a-phenyl-N-tert-butyl-nitrone (PBN) in rats. Free Radic Res Commun, 1990, 9, 317-23.
5. Hawthorne M.F., Strahm R.D. Kinetics of the thermal isomeriaza-tion of 2-tert-butyl-3-phenyloxazirane. J Org Chem, 1957, 22, 1263-4.
6. Janzen E.G. Spin trapping. Acc Chem Res, 1971, 4, 31-40.
7. Janzen E.G., Blackburn B.J. Detection and identification of short-lived free radicals by electron spin resonance trapping techniques (spin trapping). Photolysis of organolead, -tin, and -mercury compounds. J Am Chem Soc, 1969, 91, 4481-90.
8. Maples K.R., Green A.R., Floyd R.A. Nitrone-related therapeutics: potential of NXY-059 for the treatment of acute ischaemic stroke. CNS Drugs, 2004, 18, 1071-84.
9. Floyd R.A., Kotake Y., Hensley K., Nakae D., Konishi Y. Reactive oxygen species in choline deficiency induced carcinogenesis and nitrone inhibition. Mol Cell Biochem, 2002, 234/235, 195-203.
10. Ghoshal A.K., Rushmore T.H., Buc-Calderon P., Roberfroid M., Farber E. Prevention by Free Radical Scavenger AD5 of Prooxidant Effects of Choline Deficiency. Free Radic Biol Med, 1990, 8, 3-7.
11. Ghoshal A.K., Monserrat A.J., Porta E.A., Hartroft W.S. Role of lipoperoxidation in early choline deficiency. Exp Cell Res, 1970, 12, 31-5.
12. Takada NH., Matsuda T., Otoshi T., Yano., Otani S., Hasegawa T., Nakae D., Konishi Y., Fukushima S. Enhancement by organosulfur compounds from garlic and onions of diethylnitrosamine-induced glutathione S-transferase positive foci in the rat liver. Cancer Res, 1994, 54, 2895-9.
13. Kobayashi E., Tsujiuchi T., Nakae D., Mizumoto Y., Andoh N., Endoh T. et al. Inhibitory effects of N, N'-diphenyl-p-pheny-lenediamine on the early stage of the enhanced hepatocarcino-genesis caused by coadministration of ethionine and a choline-deficient L-amino acid-defined diet in rats. Exp Toxic Pathol, 1996, 48, 275-82.
14. Nakae D., Kotake Y., Kishida H., Hensley K.L., Denda A., Kobayashi Y. et al. Inhibition by phenyl N-tert-butyl nitrone on early phase carcinogenesis in the livers of rats fed a choline-deficient, L-amino acid-defined diet. Cancer Res, 1998, 58, 4548-51.
15. Nakae D., Kishida H., Enami T., Konishi Y., Hensley K.L., Floyd R.A. et al. Effects of phenyl N-tert-butyl nitrone and its derivatives on the early phase of hepatocarcinogenesis in rats fed a choline-deficient, l-amino acid-defined diet. Cancer Sci, 2003, 94, 26-31.
16. Doblas S., Saunders D., Tesiram Y., Kshirsager P., Pye Q., Oblander J. et al. Phenyl-tert-butyl-nitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model. Free Radical Biology & Medicine, 2007, 44, 63-72.
17. Garteiser P., Doblas S., Watanabe Y., Saunders D., Hoyle J., Lerner M. et al. Multiparametric assessment of the anti-glioma properties of OKN007 by magnetic resonance imaging. J Magn Reson Imaging, 2010, 31, 796-806.
18. Floyd R.A., Towner R.A., Wu D., Abbott A., Cranford R., Branch D. et al. Anti-cancer activity of nitrones in the Apc(Min/+) model of colorectal cancer. Free Radic Res, 2010, 44, 108-17.
19. Jacoby R.F., Marshall D.J., Newton M.A., Novakovic K., Tutsch K., Cole C.E. et al. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res, 1996, 56, 710-4.
20. Jacoby R.F., Seibert K., Cole C.E., Kelloff G., Lubet R.A. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res, 2000, 60, 5040-4.
21. Rao C.V., Cooma I., Rodriguez J.G., Simi B., El Bayoumy K., Reddy B.S. Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1, 4-phenylene bis(methylene)selenocyanate. Carcinogenesis, 2000, 21, 617-21.
22. Nakae D., Uematsu F., Kishida H., Kusuoka O., Katsuda S., Yoshida M. et al. Inhibition of the development of hepatocellular carcinomas by phenyl N-tert-butyl nitrone in rats fed with a choline-deficient, L-amino acid-defined diet. Cancer Lett, 2004, 206, 1-13.
23. Kotake Y., Kishida H., Nakae D., Floyd R.A. Nitric Oxide Production by Primary Liver Cells Isolated from Amino Acid Diet Fed Rats. Methods Enzymol, 2005, 396, 535-41.
24. Floyd R.A., Kotake Y., Towner R.A., Guo W.-X., Nakae D., Konishi Y. Nitric Oxide and Cancer Development. J Toxicol Pathol, 2007, 20, 77-92.
25. Miyajima T., Kotake Y. Spin trapping agent, phenyl N-tert-butyl nitrone, inhibits induction of nitric oxide synthase in endotoxin-induced shock in mice. Biochem Biophys Res Commun, 1995, 215, 114-21.
26. Kotake Y., Sang H., Miyajima T., Wallis G.L. Inhibition of NF-kB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN). Biochim Biophys Acta, 1998, 1448, 77-84.
27. Tabatabaie T., Graham K.L., Vasquez A.M., Floyd R.A., Kotake Y. Inhibition of the cytokine-mediated inducible nitric oxide synthase expression in rat insulinoma cells by phenyl N-tert-butylnitrone. Nitric Oxide: Biology & Chemistry, 2000, 4, 157-67.
28. Torok N.J., Higuchi H., Bronk S., Gores G.J. Nitric oxide inhibits apoptosis downstream of cytochrome c release by nitrosylating caspase 9. Cancer Res, 2002, 62, 1648-53.
29. Radisavljevic Z. Nitric oxide suppression triggers apoptosis through the FKHRL1 (FOXO3A)/ROCK kinase pathway in human breast carcinoma cells. Cancer, 2003, 97, 1358-63.
30. Kampa M., Hatzoglou A., Notas G., Niniraki M., Kouroumalis E., Castanas E. Opioids are non-competitive inhibitors of nitric oxide synthase in T47D human breast cancer cells. Cell Death Differ, 2001, 8, 943-52.
31. Azad N., Vallyathan V., Wang L., Tantishaiyakul V., Stehlik C., Leonard S.S. et al. S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation. A novel antiapoptotic mechanism that suppresses apoptosis. J Biol Chem, 2006, 281, 34124-34.
32. Yamamoto M., Yang G., Hong C., Liu J., Holle E., Yu X. et al. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest, 2003, 112, 1395-406.
33. Yu C.X., Li S., Whorton A.R. Redox regulation of PTEN by S-nitrosothiols. Mol Pharmacol, 2005, 68, 847-54.
34. Janzen E.G. A critical review of spin trapping in biological systems. In: Pryor W.A., editor. Free radicals in biology: Academic Press, Inc., 1980, p. 115-54.
35. Janzen E.G., Stronks H.J., DuBose C.M., Poyer J.L., McCay P.B. Chemistry and biology of spin-trapping radicals associated with halocarbon metabolism in vitro and in vivo. Environ Health Perspect, 1985, 64, 151-70.
36. Thornalley P.J. Theory and bilogical application of the electron spin resonance technique of spin trapping. In. Life Chemistry Reports; 2010; p. 1-56.
37. Rosen G.M., Cohen M.S., Britigan B.E., Pou S. Application of spin traps to biological systems. Free Radic Res Commun, 1990, 9, 187-95.
38. Tomasi A., Iannone A. ESR spin-trapping artifacts in biological model systems. In: Berliner L.J., Reuben J., editors. EMR of Paramagnetic Molecules. New York, NY: Plenum Press; 1993; p. 353-84.
39. Mason R.P., Hanna P.M., Burkitt M.J., Kadiiska M.B. Detection of oxygen-derived radicals in biological systems using electron spin resonance. Environ Health Perspect, 1994, 102 Suppl 10, 33-6.
40. Rosen G.M., Britigan B.E., Halpern H.J., Pou S. Free Radicals: Biology and Detection by Spin Trapping. In. New York: Oxford Unicersity Press; 1999.
41. Rhodes C.J. Toxicology of the Human Environment: The Critical Role of Free Radicals. In. New York: Taylor & Francis; 2000.
42. Towner R.A. Chemistry of spin-trapping in toxicology of the human environment: The Critical Role of Free Radicals. In: Rhodes C.J., editor. New York: Taylor & Francis; 2000; p. 7-24.
43. Williams H.E., Claybourn M., Green A.R. Investigating the free radical trapping ability of NXY-059, S-PBN and PBN. Free Radic Res, 2007, 41, 1047-52.
44. Janzen E.G., Haire D.L., Coulter G.A., Stronks H.J., Krygsman P.H., Towner R.A. et al. Locating Spin Traps in Heterogenious Media by 13C NMR Spectorscopy. The Journal of Organic Chemistry, 1989, 54, 2915-20.
45. McCay P.B., Lai E.K., Poyer J.L., DuBose C.M., Janzen E.G. Oxygen-and carbon-centered free radical formation during carbon tetrachloride metabolism. Observation of lipid radicals in vivo and in vitro. J Biol Chem, 1984, 259, 2135-43.
46. Janzen E.G., Towner R.A., Haire D.L. Detection of free radicals generated from the in vitro metabolism of carbon tetrachloride using improved ESR spin trapping techniques. Free Radic Biol Med, 1987, 3, 357-64.
47. Nakae D., Hideki K., Osamu K., Ayumi D., Kotake Y., Hensley K. et al. Inhibition by phenyl N-tert-butyl nitrone of the development of hepatocellular carcinoma by a choline-deficient, L-amino acid-defined diet in male Fischer 344 rats. American Assocation for Cancer Research Late Breaking Abst. Prog. Suppl. April 1-5, 2000. Ref Type: Abstract
48. Morimoto-Tomita M., Uchimura K., Bistrup A., Lum D.H., Egeblad M., Boudreau N. et al. Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer. Neoplasia, 2005, 7, 1001-10.
49. Uchimura K., Morimoto-Tomita M., Bistrup A., Li J., Lyon M., Gallagher J. et al. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem, 2006, 7, 2.
50. Chandru H.K., Towner R.A., Floyd R.A. Inhibition of extracellular sulfatase 2 as a possible mechanism to partially explain the anticancer activity of the nitone OKN007. American Assocation for Cancer Research. 2010. Ref Type: Abstract.